Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
in Life Science, preferable Cell Biology, Biomedicine, or Computational Biology Curious mind-set with a strong interest in fundamental Cell cycle, DNA replication and Genome integrity At least one
-
Hematopoietic stem and progenitor cells (HSPCs) are responsible for lifelong maintenance of the blood system, yet their function progressively declines with age. Chronic inflammation, a hallmark of aging
-
PhD within the last 6 years in a relevant field (e.g., chemical biology, organic chemistry, synthetic biology, computational chemistry or biology, materials science, human cell biology, physiology and
-
. Mitchell, R. J. Carmody, “NF-κB and the Transcriptional Control of Inflammation” in International Review of Cell and Molecular Biology (Elsevier, 2018; https://linkinghub.elsevier.com/retrieve/pii
-
the Broad Institute of Harvard and MIT. Current areas of focus in the lab include: Leukemia biology (pathogenesis, hematopoiesis, and stem cell biology) Dendritic cell development, function, and malignant
-
University of North Carolina at Chapel Hill | Chapel Hill, North Carolina | United States | 1 day ago
. The goals of the Rich Lab are to identify novel therapeutic paradigms in the treatment of advanced cancers, primarily malignant brain tumors, through the prism of stem cell biology to identify core regulatory
-
hours as appropriate. Qualifications PhD in stem cell and regenerative biology or cell and molecular biology or a closely related field and/or an equivalent graduate degree plus at least five years of
-
differentiation models. Applicants should hold (or be close to completing) a PhD in molecular biology, stem cell biology, genetics or a related discipline, with strong technical skills in cell and molecular biology
-
-resistant fiber types. The project offers a highly interdisciplinary environment at the interface of developmental biology, stem cell biology, genetics, and regenerative medicine, with strong translational
-
for collecting umbilical cord blood from the operating room and isolating CD34+ stem cells from this blood. Through a culturing process, you will expand and differentiate these CD34+ stem cells into large